GLP-1 microdosing is an emerging practice where individuals take sub-therapeutic doses of GLP-1 medications typically 0.05 to 0.25mg of semaglutide weekly versus the standard 0.25 to 2.4mg to minimize side effects while achieving gradual weight loss and metabolic benefits
Several physiological factors may potentially contribute to tiredness in patients taking these medications
Surgeons need to start routinely measuring fat-soluble vitamins A, D, E, and K in weight-loss patients, because when they lose fat, they lose these vitamins
Silky Patel emphasizes that adherence to this dosing schedule is essential for safety and for optimizing the injections role within a broader weight management strategy
Phentermine is contraindicated in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, agitated states, history of drug abuse, and during or within 14 days of taking monoamine oxidase inhibitors (MAOIs)